The Philippine Council for Health Research and Development (PCHRD) recently approved two health research projects from the Central Luzon Health Research and Development Consortium (CLHRDC) for FY 2015.


The health research projects are entitled: “Canine Rabies Vaccination Outcome Monitoring and its Implication to Rabies Control and Prevention Program in Pampanga” and “Isolation and Molecular Identification of Lactic Acid Bacteria (LAB) from Nile Tilapia (Oreochomis niloticus) as Potential Pathogen Antagonist”. Both projects have a one-year project duration and are from Angeles University Foundation and Pampanga State Agricultural University amounting to P499,445.00 and P445,372.50, respectively.


The assistance is through the Regional Research Fund (RRF) Initiative which is viewed as a way to encourage beginning researchers to be actively involved in health research activities without having to compete with more experienced researchers. These RRF projects are intended to build up the capabilities of individual researchers in designing, implementing and managing health research projects.


CLHRDC continues to accept and review research proposals which address priority health problems/issues identified in the Regional Unified Health Research Agenda (RUHRA) and/or National Unified Health Research Agenda (NUHRA) of the Philippine National Health Research System (PNHRS). Regular staff and faculty members of research institutes, medical and paramedical schools, hospitals and other health related agencies may submit proposals to the consortium, properly endorsed by the head of the agency.


Qualified proposals may also be endorsed by the consortium to other funding agencies such as the DOH-RO III, CHED-RO III and DOST – III. 



I.        Eligible entities:

Health researchers and faculty members of CLHRDC member-institutions and other higher education institutions (HEIs) in Region III actively involved in health-related research activities.

II.      Proposals must be related to the PCHRD-DOST Health Research Agenda and Priority Areas:

1.        Drug Discovery and Development:

Discovery of new drugs from natural substances (herbal and marine/terrestrial sources) which can be developed up to the pre-clinical stage for common infectious diseases and lifestyle-related disorders.

2.        Development of Diagnostic kits for Priority Diseases:

Development of diagnostic tests (point of care and confirmatory) for priority infectious and lifestyle-related diseases for the early detection and/or prediction of disease and mortality, utilizing existing technologies that are off-patent or lapsed technology and/or novel technology.

(dengue and dengue-like illnesses; MDR/XTR TB; drug-resistant malaria; influenza-like illnesses leptospirosis; sepsis; myocardial infarction; colorectal cancer; stroke, diabetes mellitus; and breast cancers )

3.        Genomic and Molecular Technology:

Use of information in the human genome in the design of vaccines, therapeutics, and diagnostic devices or products.

(e.g. biomarkers for early detection of diseases and target markers for treatment; personalized medicine; adult stem cells; biologics)

4.        ICT for Health:

Development of user-friendly ICT solutions to accelerate the gathering and processing of health-related information for policy making and to deliver quality health care services.

(e.g. Public health surveillance/health intelligence systems; telehealth services and systems; interface for ICT-enabled devices)

5.        Hospital Equipment and Biomedical Devices:

Development of affordable, safe and reliable hospital equipment and biomedical devices.

(e.g. ventilator/respirator; prosthesis; minimally-invasive surgery and rehabilitation equipment and e=instruments using optics and robotics)

III.   Capsule proposal format:

1.        Project Information:

i.        Project Title

ii.     Brief summary of research experiences and accomplishments of project leader and researchers that qualifies them to undertake the research work (without identifying the specific persons who will undertake the project so RMC/ERC can do a blind evaluation).

2.       Significance of the Proposal

Describe the project rationale and significance of the proposed project to the current health-related needs of the country.

3.        Project Objectives

Statement of the specific purpose to be addressed by the project on the problem areas identified.

4.        Brief Methodology

Approach on how the associated work products, processes, information and services will be implemented, developed and acquired.

IV.   E-Submission of capsule proposals:

Proposals must be submitted to the CLHRDC Secretariat via electronic mail. Send your capsule proposals to This email address is being protected from spambots. You need JavaScript enabled to view it.. Eligible entities whose proposals have been evaluated will be notified accordingly regarding the results of the evaluation.

If the proposal will be found eligible, the proponent will then be asked to develop the full-blown proposal (together with the duly accomplished Ethics Protocol) for joint RMC/ERC review.






1.    E-Submission of capsule proposals

Up to October 31, 2014

Submit to CLHRDC Secretariat thru: This email address is being protected from spambots. You need JavaScript enabled to view it. . Proposals will be forwarded to RMC members who will conduct the review.

2.    Preliminary review and evaluation

Within 10 working days after the receipt of the proposal

Assigned evaluators from the Research Management Committee (RMC) will conduct review and prepare evaluation report.

3.    Notification of proponents

Within 2 working days after the results of the review become available

Proponents will be informed whether their proposals passed the preliminary screening or not. Qualified researches will be developed into full-blown proposals. A letter of intent from the head of the institution shall be attached to the proposal upon submission.

4.    Joint RMC/ERC evaluation of full-blown research proposals (for projects found eligible during preliminary screening)

Within than 1 month after submission

The RMC and ERC will jointly review the full-blown proposal. Proponents will be provided with a copy of the evaluation report as a guide in revising the proposal.

5.    Endorsement of Qualified Proposals to Funding Institutions

Within 1 week after the submission of revised proposal and other related documents

The CLHDRC Chairperson shall endorse proposals that have passed the criteria for evaluation.